DiscoverBackTable Cardiology
BackTable Cardiology
Claim Ownership

BackTable Cardiology

Author: BackTable Inc.

Subscribed: 7Played: 294
Share

Description

BackTable Cardiology is a podcast for clinical and interventional cardiologists, cardiac surgeons, and other healthcare professionals involved in cardiovascular care. This show brings together expert voices from across the field to explore the latest in cardiology—from evolving guidelines and innovative devices to real-world case discussions and multidisciplinary collaboration. BackTable Cardiology delivers practical insights and forward-thinking conversations to keep you connected and current in a rapidly changing specialty.

63 Episodes
Reverse
In 1990, Dr. John Lasala watched one of the first coronary stents go into a failing artery and called it “the future of cardiology.” Now he and Dr. Aloke Finn see drug-coated balloons as a possible next shift: treating the artery without leaving a permanent implant behind. On this episode of BackTable Cardiology, Dr. Sameh Sayfo is joined by Dr. Lasala and Dr. Finn to trace coronary intervention from balloon angioplasty to drug-eluting stents, then explain how paclitaxel and sirolimus differ in the arterial wall and what it takes to keep sirolimus in the wall long enough to work. Dr. Lasala, who spent his early research career watching less than 1% of drug reach the vessel wall, admits that 20 years ago he would have called 90 days of drug retention impossible. They also explain why vessel preparation with imaging and specialty balloons must come first. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by Cordishttps://cordis.com/na/home --- Timestamps 00:00 - Introduction01:46 - From Balloon Angioplasty to Drug-Eluting Stents07:43 - Paclitaxel Versus Sirolimus: Cytotoxic Versus Cytostatic11:35 - Vessel Preparation Before a Drug-Coated Balloon14:18 - Imaging and Specialty Balloons for Restenotic Tissue16:42 - Keeping Sirolimus in the Vessel Wall21:09 - Inflation Time, Pressure, and Balloon Technique28:47 - Three Types of In-Stent Restenosis31:52 - Neoatherosclerosis and Calcified Neointima34:30 - Vessel Size and Small-Vessel Restenosis36:41 - DAPT for Patients at High Bleeding Risk40:15 - Research Needs and the Future of Drug-Coated Balloons43:53 - Closing Remarks --- More about this episode The conversation then turns to technique: contact, inflation time and pressure, why a drug-coated balloon is a drug delivery vehicle rather than a dilation tool, and why one balloon should not be stretched across several segments. Drs. Lasala and Finn compare their approach to three kinds of in-stent restenosis, from old bare metal stents to multiple stent layers, explain how neoatherosclerosis changes the target, and discuss small vessels and shorter dual antiplatelet therapy for patients at high bleeding risk. They close on the randomized data still needed and why uncaging the vessel could become the third revolution in coronary intervention. --- Resources Heldman AW, et al. Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis. Circulation. 2001https://doi.org/10.1161/01.CIR.103.18.2289 Cutlip DE, et al. Sirolimus-Eluting Balloon vs. Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis (SELUTION4ISR). J Am Coll Cardiol. 2026https://doi.org/10.1016/j.jacc.2026.03.021 Large De-NOVo Coronary artEry Disease Treated With Sirolimus Drug Eluting Balloon (LOVE DEB). ClinicalTrials.gov NCT05915468https://clinicaltrials.gov/study/NCT05915468 --- BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
A creatinine of 0.9 can hide a GFR of 45, and at Columbia that gap is now called out in every cath lab time-out. On this episode of BackTable Cardiology, Dr. Sameh Sayfo talks with Dr. Megha Prasad, interventional cardiologist and co-director of the interventional cardiology fellowship at Columbia University, about the side of the cath lab most fellows are never taught: quality improvement, operations, and making the case for new technology. Dr. Prasad traces her interest back to root cause analyses during residency, explains who really defines quality, and walks through two initiatives, a contrast checkpoint to prevent acute kidney injury and a standardized weaning protocol for mechanical circulatory support. She also explains why awareness and an operator's own data move colleagues more than penalties, and how fellows can become a lab's standard keepers. --- Get the BackTable apphttps://www.backtable.com/app --- This podcast is supported by an educational grant from Chiesi. --- Timestamps 00:00 - Introduction03:10 - From Root Cause Analysis to Quality Improvement05:20 - Who Defines Quality in the Cath Lab?07:50 - A Time-Out Checkpoint to Prevent Contrast-Associated AKI11:55 - Winning Buy-In Without Penalties16:04 - Engaging Fellows in Quality Improvement21:04 - When Quality Metrics Go Too Far27:30 - Cath Lab Turnover and Team Morale33:02 - Building a Culture of Respect in the Cath Lab41:45 - Learning to Talk With Hospital Administration45:54 - Making the Case for New Therapies51:28 - Closing Remarks --- More about this episode The doctors then discuss what happens when quality metrics go too far: public reporting that can push operators away from the most complex patients, and why Dr. Prasad thinks interventionalists, like artists, must choose which outside feedback to take. She describes how team morale drives cath lab turnover, why a hierarchical cath lab is a dangerous one, and how physicians can learn the art of negotiation with hospital administration. They close on leaving ego at the door, backing every request for a new therapy with data, and how patients informed by AI are changing the conversation. --- Resources Dr. Megha Prasad, Columbia University Department of Medicine, Division of Cardiology profilehttps://www.columbiacardiology.org/profile/megha-prasad-md NCDR CathPCI Registry, American College of Cardiologyhttps://cvquality.acc.org/NCDR-Home/registries/hospital-registries/cathpci-registry --- BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Renal denervation is back in the guidelines, but what does the latest evidence mean for patient selection, technique, and counseling in the cath lab? On this episode of BackTable Cardiology, Dr. Vladimir Lakhter interviews Dr. Dmitriy Feldman, director of endovascular services in the Division of Cardiology at Weill Cornell Medicine, about where renal denervation fits in hypertension care today. They cover the new guideline recommendation, the history behind the procedure's comeback, the referral pathway and pre-procedural workup, and how to counsel patients on what to expect. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction02:42 - Guideline Recommendations for Renal Denervation05:36 - Lessons From Early Sham-Controlled Trials12:15 - Referral Pathways and Hypertension Programs17:16 - Pre-Procedural Workup and Imaging23:11 - Patient Selection and Counseling29:09 - Durability of Blood Pressure Reduction31:46 - Radiofrequency Denervation Technique42:44 - Ultrasound Denervation Technique45:38 - Sedation and Pain Management49:06 - Complication Management53:10 - Future Directions in Denervation58:05 - Closing Remarks --- More about this episode Dr. Feldman, a co-author of the 2023 SCAI position statement on renal denervation, explains why the first large sham-controlled trial missed its primary endpoint and how off-medication trials, ambulatory blood pressure endpoints, and multielectrode catheters changed the picture. He then walks through the procedure itself: CT angiography for anatomic screening, vessel sizing for radiofrequency ablation of the main renal arteries and their branches, wire selection for tortuous anatomy, how the ultrasound balloon system differs, sedation for a painful procedure, and preparation for rare complications. He also shares why he tells patients that renal denervation is not a cure but a one-time treatment with a long-term effect. The episode closes with a look at what may come next, from nerve stimulation and multi-organ denervation to possible metabolic and rhythm benefits, and why hypertension deserves a central place in cardiovascular prevention. --- Resources Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2025https://doi.org/10.1161/HYP.0000000000000249 Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations. JSCAI. 2023https://doi.org/10.1016/j.jscai.2023.101121 A Controlled Trial of Renal Denervation for Resistant Hypertension (SYMPLICITY HTN-3). N Engl J Med. 2014https://doi.org/10.1056/NEJMoa1402670 Efficacy of Catheter-Based Renal Denervation in the Absence of Antihypertensive Medications (SPYRAL HTN-OFF MED Pivotal). Lancet. 2020https://doi.org/10.1016/S0140-6736(20)30554-7 Long-Term Efficacy and Safety of Renal Denervation in the Presence of Antihypertensive Drugs (SPYRAL HTN-ON MED). Lancet. 2022https://doi.org/10.1016/S0140-6736(22)00455-X Endovascular Ultrasound Renal Denervation to Treat Hypertension (RADIANCE II). JAMA. 2023https://doi.org/10.1001/jama.2023.0713 A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN). Circulation. 2019https://doi.org/10.1161/CIRCULATIONAHA.118.037654 American Heart Association. Hypertension Center Certificationhttps://www.heart.org/HypertensionCertification BackTable Cardiology: Renal Denervation: Innovations in Hypertension Managementhttps://www.backtable.com/shows/cardiology/podcasts/26/renal-denervation-innovations-in-hypertension-management Dr. Dmitriy Feldman, Weill Cornell Medicinehttps://weillcornell.org/dnfeldman Dr. Vladimir Lakhter, BackTable contributor pagehttps://www.backtable.com/shows/cardiology/contributors/dr-vladimir-lakhter --- BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
Drug-coated balloons and a head-to-head trial against lithotripsy have put cutting and scoring balloons back at the center of complex percutaneous coronary intervention (PCI). On this episode of BackTable Cardiology, Dr. Nyal Borges interviews Dr. Ziad Ali, director of the DeMatteis Cardiovascular Institute, for an in-depth look at the mechanics, selection, and technique behind cutting and scoring balloons in complex PCI. They cover how these devices create a controlled dissection in fibrolipidic plaque, why they only fracture calcium that sits right at the lumen, and how lesion type and imaging should guide the choice between a conventional balloon, a specialty balloon and intravascular lithotripsy. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction02:30 - Mechanism of Cutting and Scoring Balloons06:13 - Superficial Calcium and Balloon Undersizing08:39 - Focal Force and Calcium Fracture11:35 - Device Selection and Lesion Length15:46 - In-Stent Restenosis, Drug-Coated Balloons and Ostial Lesions19:52 - Procedural Sequence and Balloon Sizing24:18 - Sizing Without Imaging and Multiple Inflations26:43 - Enhanced Stent Visualization as a Procedural Endpoint29:29 - Complications and Branch Vessel Safety33:14 - Hematoma Fenestration in Dissection and SCAD37:30 - Take-Home Points and Closing Remarks --- More about this episode Dr. Ali shares why he deliberately undersizes balloons for calcified lesions so the blades, not the balloon, do the work, and why a specialty balloon should be the first device for in-stent restenosis. The conversation covers patient and lesion selection, procedural sequence, imaging strategies, and practical safety pearls. They discuss how to size and position the balloon, when to avoid branch vessels, and why enhanced stent visualization, not angiographic appearance alone, tells you when the lesion is prepared. The episode closes with Dr. Ali’s take-home advice: do not fear specialty balloons, match your strategy to your goal, and use imaging to tailor your approach to each patient. --- Resources Cutting Balloon to Optimize Predilation for Stent Implantation: The COPS Randomized Trial. Catheter Cardiovasc Interv. 2023https://doi.org/10.1002/ccd.30603 PREDICTION: Randomized Trial of Cutting Balloon Versus Conventional Balloon Predilation in Severely Calcified Coronary Lesions (jRCT trial record)https://jrct.mhlw.go.jp/latest-detail/jRCTs052200044 ShortCUT: Randomized Trial of Intravascular Lithotripsy Versus Cutting Balloon in Calcified Coronary Disease (trial record)https://clinicaltrials.gov/study/NCT06089135Intravascular Ultrasound-Derived Calcium Score to Predict Stent Expansion in Severely Calcified Lesions. Circ Cardiovasc Interv. 2021https://doi.org/10.1161/CIRCINTERVENTIONS.120.010296 A New Optical Coherence Tomography-Based Calcium Scoring System to Predict Stent Underexpansion. EuroIntervention. 2018https://doi.org/10.4244/EIJ-D-17-00962 BackTable Cardiology Episode 14. COSIRA II: Refractory Angina Challenges & Treatment Strategies, with Dr. Ziad Alihttps://www.backtable.com/shows/cardiology/podcasts/14/cosira-ii-refractory-angina-challenges-treatment-strategies Dr. Ziad Ali, Catholic Health physician profilehttps://doctors.catholichealthli.org/provider/ziad-anwar-ali/2404986 Dr. Nyal Borges, Atrium Health physician profilehttps://atriumhealth.org/provider-profile/nyal-borges-1790042448 --- BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
What does it actually take to open a chronically occluded pulmonary artery without pushing the patient into reperfusion pulmonary edema? On this episode of BackTable Cardiology, Dr. Hady Lichaa interviews Dr. Riyaz Bashir, interventional cardiologist and vascular medicine specialist at Mayo Clinic in Jacksonville, about the real-world, table-side technique of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension (CTEPH). They walk through vascular access, telescoping sheath setup, right heart catheterization, pressure wire guidance, balloon sizing, and step-by-step planning for each lobe and lesion. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction02:48 - Procedural Setup and Vascular Access06:31 - Sheath in Sheath Technique11:20 - Guide Catheter Selection17:53 - Wire Selection and Balloon Undersizing22:12 - Crossing Chronic Total Occlusions27:25 - Pulmonary Collaterals and Flush Occlusions32:33 - Guide Extensions and Contrast Reduction36:38 - Distal Perfusion Pressure Targets41:26 - Pressure Wire Selection and Wire Management45:54 - Balloon Sizing and Reperfusion Pulmonary Edema54:04 - Hemoptysis and Gelatin Sponge Embolization1:02:32 - Closing Remarks --- More about this episode Dr. Bashir describes a technique he has simplified over ten years, built around a single principle that the goal of the procedure is perfusion rather than a better looking angiogram. He explains why early sessions use deliberately undersized balloons to restore flow safely, how these lesions behave like scar tissue, and why retrograde approaches are risky in fragile pulmonary vessels. The discussion covers practical strategies for keeping distal pressure low, managing hemoptysis with balloon tamponade and gelatin sponge embolization, and staging treatment over several sessions. The discussion closes with advice on mechanical circulatory support planning and the judgment, preparation, and teamwork that make high-risk BPA safe and effective. --- Resources Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined Balloon Pulmonary Angioplasty for Inoperable Patients With Chronic Thromboembolic Pulmonary Hypertension. Circ Cardiovasc Interv. 2012https://doi.org/10.1161/CIRCINTERVENTIONS.112.971077 Auger WR, et al. Balloon Pulmonary Angioplasty for Treatment of Chronic Thromboembolic Pulmonary Hypertension: Statement From the BPA-CTEPH Alliance. JACC Cardiovasc Interv. 2026https://doi.org/10.1016/j.jcin.2026.02.033 Nasri A, Bashir R, Lakhter V. Management of Complications of Balloon Pulmonary Angioplasty. Card Electrophysiol Clin. 2025https://doi.org/10.1016/j.ccep.2024.12.015 Lang IM, et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry. J Am Coll Cardiol. 2025https://doi.org/10.1016/j.jacc.2025.04.021 Aggarwal V, et al. Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension. A Scientific Statement From the American Heart Association. Circulation. 2024https://doi.org/10.1161/CIR.0000000000001197 Inami T, et al. Pulmonary Edema Predictive Scoring Index (PEPSI), a New Index to Predict Risk of Reperfusion Pulmonary Edema and Improvement of Hemodynamics in Percutaneous Transluminal Pulmonary Angioplasty. JACC Cardiovasc Interv. 2013https://doi.org/10.1016/j.jcin.2013.03.009 BackTable Cardiology Episode 36. Understanding CTEPH, Diagnostic and Interventional Techniqueshttps://www.backtable.com/shows/cardiology/podcasts/36/understanding-cteph-diagnostic-interventional-techniques Dr. Riyaz Bashir, Mayo Clinic, Jacksonvillehttps://www.mayoclinic.org/biographies/bashir-riyaz-m-b-b-s-m-d/bio-20590757 Dr. Hady Lichaa, BackTable contributor pagehttps://backtable.com/shows/vi/contributors/dr-hady-lichaa Dr. Hady Lichaa, Ascension Saint Thomas Hearthttps://healthcare.ascension.org/doctors/1336267533/hady-t-lichaa-murfreesboro-tn --- BackTable Cardiology is the go-to podcast for interventional cardiologists, cardiac surgeons, and other healthcare professionals that manage cardiovascular conditions. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app
loading
Comments